What's Happening?
Tennessee has enacted a new law prohibiting pharmacy benefit managers (PBMs) from owning pharmacies, aiming to curb vertical integration in the healthcare sector. This law, set to take effect in 2028, is facing legal challenges from PBM lobby groups and
major companies like CVS Caremark and Cigna's Express Scripts. The plaintiffs argue that the law is unconstitutional and preempted by federal law, citing potential negative impacts on rural healthcare access and the state economy.
Why It's Important?
The legal battle over Tennessee's pharmacy law underscores the ongoing tension between state regulations and the operations of large PBMs. These companies play a significant role in negotiating drug prices, and the outcome of this case could have far-reaching implications for healthcare costs and access. If upheld, the law could set a precedent for other states seeking to regulate PBMs, potentially reshaping the landscape of the pharmaceutical industry and impacting drug pricing strategies nationwide.
What's Next?
The lawsuits filed against Tennessee's law will proceed in the US District Court for the Middle District of Tennessee. The court's decision will be closely watched by other states and stakeholders in the healthcare industry. If the law is upheld, it may encourage similar legislative efforts in other states. Conversely, if the law is struck down, it could reinforce the position of PBMs and influence future regulatory approaches. The case may also prompt further discussions at the federal level regarding the regulation of PBMs and their role in the healthcare system.
